Screener
Charles River Laboratories CRL Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Business | ||||||
| DSA | $606.51M-1.9% | $596.92M+0.7% | $591.57M-2.0% | $600.69M-2.3% | $618.03M-1.5% | |
| Manufacturing | $188.1M-6.3% | $190.54M+6.8% | $196.4M+0.7% | $190.69M-3.1% | $200.84M+4.4% | |
| RMS | $209.48M-1.8% | $208.37M-2.2% | $206.26M+1.0% | $213.47M+7.9% | $213.27M+3.3% | |
| Total Revenue by Geography | ||||||
| Asia Pacific | $60.52M+11.0% | $55.48M+32.3% | $56.91M+2.0% | $51.66M+14.8% | $54.5M+8.2% | |
| Canada | $127.51M-6.0% | $109.57M-12.6% | $123.28M+3.3% | $116.81M-8.1% | $135.59M+8.3% | |
| Europe | $263.07M-6.7% | $277.58M+5.4% | $279.9M+6.3% | $277.69M+4.0% | $281.86M+3.9% | |
| Other | $13.12M+27.0% | $9.4M-43.6% | $16.79M-2.0% | $21.08M+87.1% | $10.33M+34.4% | |
| U.S. | $539.86M-1.8% | $543.81M+1.3% | $517.35M-5.4% | $537.61M-3.9% | $549.86M-3.8% |
FAQ
- How does Charles River Laboratories break its business down?
- Charles River Laboratories (CRL) reports total revenue by business across 3 parts — DSA, Manufacturing and RMS. Each is extracted from the segment footnotes and tracked over time.
- Where does Charles River Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Charles River Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
